Calendar

RECRUITINGphase readoutNCT06989112: DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Endometrial Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT07459712: Pharmacokinetics and Pharmacodynamics of THS With LEVIA Compared to THS With TEREA and to Cigarettes

Sponsor: Philip Morris Products S.A.. Phase: NA. Conditions: Nicotine

full page →ctgov ↗

COMPLETEDphase readoutNCT00932412: The CLARA Study From the Acute Leukemia French Association (ALFA 0702 Trial)

Sponsor: Hospices Civils de Lyon. Phase: PHASE2. Conditions: Acute Myeloid Leukemia

full page →ctgov ↗

COMPLETEDphase readoutNCT06883812: Continuous Glucose Monitoring in Prediabetes With Health Education Videos Among Community Health Workers

Sponsor: David S Black, PhD. Phase: NA. Conditions: Prediabetes

full page →ctgov ↗

COMPLETEDphase readoutNCT07275112: Cross-cultural an Reliability and Validity Evaluation of TENDINS-A in Spain

Sponsor: Cardenal Herrera University. Phase: . Conditions: Achilles Tendinopathy

full page →ctgov ↗

COMPLETEDphase readoutNCT07151612: The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia

Sponsor: Shanxi Eye Hospital. Phase: PHASE4. Conditions: Presbyopia

full page →ctgov ↗

COMPLETEDphase readoutNCT02841748: A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study

Sponsor: University of Chicago. Phase: PHASE2. Conditions: Head and Neck Cancer, Squamous Cell Carcinoma of the Head and Neck

full page →ctgov ↗

RECRUITINGphase readoutNCT07589348: POCD After Major Gynecologic Surgery

Sponsor: Fatihhan Zeytun. Phase: . Conditions: Postoperative Cognitive Dysfunction, Perioperative Neurocognitive Disorder

full page →ctgov ↗

RECRUITINGphase readoutNCT05985148: A Study of Stereotactic Radiosurgery (SRS) to Treat Pain in the Chest and/or Stomach Wall

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: Thoracoabdominal Wall Pain, Secondary to Parietal Pleura or Parietal Peritoneum Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT07575555: The Effect of Lipedema on Knee Osteoarthritis

Sponsor: Izmir Democracy University. Phase: . Conditions: Lipedema, Knee Osteoarthritis, Knee Acute and Chronic Pain, Knee, Knee Arthritis Osteoarthritis, Knee Arthropathy, Knee Cartilage Defects, Knee Cartilage Lesions

full page →ctgov ↗

RECRUITINGphase readoutNCT07172555: Virtual Dietetic Interventions in Patients With Coeliac

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust. Phase: NA. Conditions: Coeliac Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT07499648: Baby Steps to Care

Sponsor: University Hospitals Cleveland Medical Center. Phase: NA. Conditions: Prenatal Follow Up Care

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT06905626: Weight Gain Prevention in Adolescents and Young Adults

Sponsor: University of Minnesota. Phase: PHASE3. Conditions: Healthy Volunteers

full page →ctgov ↗

RECRUITINGphase readoutNCT05448326: The Diagnostic Observatory: Combating Diagnostic Wandering and Impasse Within the AnDDI-Rares Network

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Developmental Abnormality

full page →ctgov ↗

COMPLETEDphase readoutNCT07434258: Dose-Response Association Between Cerclage Wire Number and Infection Risk

Sponsor: Istanbul University. Phase: . Conditions: Femur Fracture, Periprosthetic Fracture of Hip, Periprosthetic Fracture of the Femur, Surgical Site Infection (SSI), Biofilms, Postoperative Complications

full page →ctgov ↗

RECRUITINGphase readoutNCT03889743: Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing

Sponsor: St. Olavs Hospital. Phase: PHASE4. Conditions: Asthma, Inflammation

full page →ctgov ↗

RECRUITINGphase readoutNCT07449715: Respiration From Pleth Validation

Sponsor: Philips Clinical & Medical Affairs Global. Phase: . Conditions: Respiratory Rate Monitoring

full page →ctgov ↗

COMPLETEDphase readoutNCT07694115: Bioequivalence Study to Compare Empagliflozin/ Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg

Sponsor: Humanis Saglık Anonim Sirketi. Phase: PHASE1. Conditions: Type 2 Diabetes Mellitus (T2DM)

full page →ctgov ↗

RECRUITINGphase readoutNCT04379115: Optimization of NIBS for Treatment of Addiction

Sponsor: Case Western Reserve University. Phase: NA. Conditions: Opioid-use Disorder, Chronic Pain

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06208215: RZ358 Treatment for Congenital Hyperinsulinism

Sponsor: Rezolute. Phase: PHASE3. Conditions: Congenital Hyperinsulinism

full page →ctgov ↗

COMPLETEDphase readoutNCT07442825: Evaluating Laser and Piezocision vs. Piezocision Alone on Root Resorption and Gingival Health During Tooth Retraction

Sponsor: Damascus University. Phase: NA. Conditions: Malocclusion, Angle Class II, Division 1

full page →ctgov ↗

WITHHELDphase readoutNCT06762340: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07154576: Central Sensitization Inventory and Symptoms of Pelvic Floor Dysfunctions

Sponsor: Żelazna Medical Centre, LLC. Phase: . Conditions: Pelvic Floor Dysfunctions

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07414589: Brief Alcohol Treatment for Women Veterans in Primary Care

Sponsor: Syracuse VA Medical Center. Phase: NA. Conditions: Alcohol Misuse

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07491068: The Accuracy and Efficacy of Large Language Model Written Hospital Course Summaries

Sponsor: Pavol Jozef Safarik University. Phase: NA. Conditions: Hospitalizations

full page →ctgov ↗

RECRUITINGphase readoutNCT06881368: Phenotypic and Etiological Characterization of Susac Syndrome

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Susac Syndrome

full page →ctgov ↗

TERMINATEDphase readoutNCT04758650: Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis

Sponsor: Universitair Ziekenhuis Brussel. Phase: PHASE2. Conditions: Solid Malignancy Located in the Head and Neck, Cancer, Carotid Stenosis, Atherosclerosis of Artery, Hodgkin Lymphoma, Adult, Non Hodgkin Lymphoma, HLH, Cardiac Sarcoidosis, Sarcoidosis

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07524374: SHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After Immunotherapy

Sponsor: Zhigang Li. Phase: PHASE2. Conditions: ESCC

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07698574: Qiling Yiqi Tablets Plus Antiretroviral Therapy for HIV Immune Non-responders With Lung-Spleen Qi Deficiency

Sponsor: Beijing University of Chinese Medicine. Phase: NA. Conditions: HIV-1 Infection, Acquired Immunodeficiency Syndrome, Immune Reconstitution Failure, Immunological Non-responder, Lung-Spleen Qi Deficiency Syndrome

full page →ctgov ↗

RECRUITINGphase readoutNCT07449091: Adaptability of an Undetectable = Untransmissible Model for HBV

Sponsor: NYU Langone Health. Phase: . Conditions: Chronic Hepatitis b, Viremia

full page →ctgov ↗

RECRUITINGphase readoutNCT01532791: Natural History Study - Mitochondrial Disease

Sponsor: Columbia University. Phase: . Conditions: MELAS or m.3243 A>G Mitochondrial DNA Mutation Carrier

full page →ctgov ↗

COMPLETEDphase readoutNCT07385391: Development of a Novel Algorithm for Real-Time Bedside Assessment of Insulin Resistance in Critically Ill Patients Based on Continuous Glucose Monitoring Data

Sponsor: Chinese Medical Association. Phase: . Conditions: Critical Illness, Metabolism Disorders, Insulin Resistance

full page →ctgov ↗

TERMINATEDphase readoutNCT06511791: An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.

Sponsor: Ferring Pharmaceuticals. Phase: PHASE1. Conditions: Infertility

full page →ctgov ↗

COMPLETEDphase readoutNCT04841174: The Effect of Abdominal Massage on Gastric Problems in Pediatric Intensive Care: A Randomized Controlled Study

Sponsor: Istanbul University - Cerrahpasa. Phase: NA. Conditions: Intensive Care Units, Pediatric, Massage, Nutrition Disorders, Nurse's Role

full page →ctgov ↗

COMPLETEDphase readoutNCT05010018: A Mobile Application to Improve Procurement and Distribution of Healthful Foods & Beverages in Baltimore City

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: Obesity

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04850118: A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP

Sponsor: Beacon Therapeutics. Phase: PHASE2. Conditions: X-Linked Retinitis Pigmentosa

full page →ctgov ↗

RECRUITINGphase readoutNCT07281118: Intercostal Cryoanalgesia in Double Lung Transplant Recipients

Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Post-operative Pain Management

full page →ctgov ↗

TERMINATEDphase readoutNCT04652518: LYT-100 in Post-acute COVID-19 Respiratory Disease

Sponsor: PureTech. Phase: PHASE2. Conditions: Covid19, Post-acute COVID-19 Respiratory Disease

full page →ctgov ↗

COMPLETEDphase readoutNCT07426497: Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia: A Randomized Controlled Trial

Sponsor: Istanbul Medeniyet University. Phase: NA. Conditions: Coccydynia, Chronic Pain, Coccygodynia

full page →ctgov ↗

SUSPENDEDphase readoutNCT06653010: Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer

Sponsor: Wondercel Biotech (ShenZhen). Phase: EARLY_PHASE1. Conditions: CRC (Colorectal Cancer), Metastatic Colorectal Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT05969860: At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma, Advanced Bladder Carcinoma, Advanced Breast Carcinoma, Advanced Carcinoid Tumor, Advanced Cervical Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastric Carcinoma, Advanced Glioblastoma, Advanced Head and Neck Carcinoma, Advanced HER2 Positive Breast Carcinoma, Advanced Lung Carcinoma, Advanced Lung Small Cell Carcinoma, Advanced Malignant Germ Cell Tumor, Advanced Malignant Solid Neoplasm, Advanced Neuroendocrine Carcinoma, Advanced Ovarian Carcinoma, Advanced Pancreatic Carcinoma, Advanced Prostate Small Cell Neuroendocrine Carcinoma, Advanced Prostate Carcinoma, Hematopoietic and Lymphoid System Neoplasm, Multiple Myeloma, Myelodysplastic Syndrome, Advanced Basal Cell Carcinoma, Advanced Cholangiocarcinoma, Advanced Endometrial Carcinoma, Advanced Esophageal Carcinoma, Advanced Fallopian Tube Carcinoma, Advanced Hepatocellular Carcinoma, Advanced Liver Carcinoma, Advanced Lymphoma, Advanced Malignant Testicular Neoplasm, Advanced Melanoma, Advanced Merkel Cell Carcinoma, Advanced Penile Carcinoma, Advanced Primary Malignant Central Nervous System Neoplasm, Advanced Renal Cell Carcinoma, Advanced Sarcoma, Advanced Skin Squamous Cell Carcinoma, Advanced Urethral Carcinoma, Advanced Vaginal Carcinoma, Advanced Vulvar Carcinoma, Advanced Appendix Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05544760: CatchU: A Quantitative Multisensory Falls-Assessment Study

Sponsor: Albert Einstein College of Medicine. Phase: NA. Conditions: Fall Injury, Age Problem, Well Aging, Sensory Disorders

full page →ctgov ↗

RECRUITINGphase readoutNCT05370820: Prevention of Postpartum Hemorrhage With Tranexamic Acid

Sponsor: Inova Health Care Services. Phase: PHASE2. Conditions: Post Partum Hemorrhage

full page →ctgov ↗

RECRUITINGphase readoutNCT01109420: Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Non-Medullary Thyroid Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06155682: TMS for Inhibition Enhancement in Schizophrenia

Sponsor: University of Maryland, Baltimore. Phase: NA. Conditions: Schizophrenia

full page →ctgov ↗

RECRUITINGphase readoutNCT07197424: The Use of Robot Assisted Magnetically Controlled Capsule Endoscopy in Patients With Iron Deficiency Anaemia

Sponsor: University of Edinburgh. Phase: NA. Conditions: Iron Deficiency Anaemia

full page →ctgov ↗

COMPLETEDphase readoutNCT06716424: A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus

Sponsor: Sanofi. Phase: PHASE4. Conditions: Type 2 Diabetes

full page →ctgov ↗

COMPLETEDphase readoutNCT04597424: Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)

Sponsor: ANRS, Emerging Infectious Diseases. Phase: PHASE3. Conditions: Unsafe Sex, Risk-Taking

full page →ctgov ↗

RECRUITINGphase readoutNCT04082520: Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Grade 1 Meningioma, Grade 2 Meningioma, Grade 3 Meningioma, Recurrent Meningioma, Unresectable Meningioma

full page →ctgov ↗

RECRUITINGphase readoutNCT05759923: First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours

Sponsor: Molecure S.A.. Phase: PHASE1. Conditions: Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma, Advanced Colorectal Carcinoma, Metastatic Pancreatic Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Renal Cell Carcinoma, Metastatic Ovarian Carcinoma

full page →ctgov ↗

Date TBD